FDA To Mull New Ideas On Biosimilar Competition, Approvals
An upcoming forum aimed at galvanizing biosimilar sales will seek fresh ideas for thwarting anti-competitive practices and streamlining approvals, the U.S. Food and Drug Administration said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article